Agile Therapeutics Statistics

Total Valuation

AGRX has a market cap or net worth of $10.43 million. The enterprise value is $7.87 million.

Market Cap	10.43M
Enterprise Value	7.87M

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

AGRX has 6.90 million shares outstanding. The number of shares has increased by 308.85% in one year.

Current Share Class	n/a
Shares Outstanding	6.90M
Shares Change (YoY)	+308.85%
Shares Change (QoQ)	+48.02%
Owned by Insiders (%)	9.50%
Owned by Institutions (%)	0.00%
Float	5.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.31
Forward PS	0.64
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.55

Current Ratio	0.55
Quick Ratio	0.28
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-16.31

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-61.55%
Return on Capital (ROIC)	n/a
Revenue Per Employee	$1.14M
Profits Per Employee	-$834,632
Employee Count	19
Asset Turnover	1.57
Inventory Turnover	1.88

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.70% in the last 52 weeks. The beta is 1.58, so AGRX's price volatility has been higher than the market average.

Beta (5Y)	1.58
52-Week Price Change	-26.70%
50-Day Moving Average	1.29
200-Day Moving Average	1.14
Relative Strength Index (RSI)	82.75
Average Volume (20 Days)	65,594

Short Selling Information

The latest short interest is 222,097, so 3.22% of the outstanding shares have been sold short.

Short Interest	222,097
Short Previous Month	213,078
Short % of Shares Out	3.22%
Short % of Float	4.32%
Short Ratio (days to cover)	0.28

Income Statement

In the last 12 months, AGRX had revenue of $21.57 million and -$15.86 million in losses. Loss per share was -$3.64.

Revenue	21.57M
Gross Profit	13.73M
Operating Income	-13.56M
Pretax Income	-7.79M
Net Income	-15.86M
EBITDA	-13.15M
EBIT	-13.56M
Loss Per Share	-$3.64

Full Income Statement

Balance Sheet

The company has $2.85 million in cash and $289,000 in debt, giving a net cash position of $2.56 million or $0.37 per share.

Cash & Cash Equivalents	2.85M
Total Debt	289,000
Net Cash	2.56M
Net Cash Per Share	$0.37
Equity (Book Value)	-21.91M
Book Value Per Share	-3.17
Working Capital	-11.79M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.71M
Capital Expenditures	n/a
Free Cash Flow	-1.71M
FCF Per Share	-$0.25

Full Cash Flow Statement

Margins

Gross margin is 63.63%, with operating and profit margins of -62.85% and -73.52%.

Gross Margin	63.63%
Operating Margin	-62.85%
Pretax Margin	-73.52%
Profit Margin	-73.52%
EBITDA Margin	-60.99%
EBIT Margin	-62.85%
FCF Margin	-48.65%

Dividends & Yields

AGRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-308.85%
Shareholder Yield	-308.85%
Earnings Yield	-152.10%
FCF Yield	-16.36%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 11, 2023. It was a reverse split with a ratio of 0.02:1.

Last Split Date	Apr 11, 2023
Split Type	Reverse
Split Ratio	0.02:1

Scores

AGRX has an Altman Z-Score of -43.02 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-43.02
Piotroski F-Score	3